Prader Willi Syndrome Clinical Trial
Official title:
Evaluation of the Effect of the Oxytocin Administered in Nasal Pulverizing on the Social Skills, the Stress, the Anxiety and the Eating Habits at Grown-up Patients Presenting a Syndrome of Prader-Willi: Pilot Study
The role of oxytocin (OT) is already known in the regulation of satiety but some clinical
studies demonstrated that OT participates also in the regulation of social behavior by its
implication on a better comprehension of emotion which plays a role on theory of mind and
empathy. By the way, these 2 behaviors are deviants for patients with Prader-Willi Syndrome
(PWS). Actually, no study was led on the effect of OT on PWS patients but Swaab and al in
1995 showed a significant reduction in number and in volume of neurons expressing OT in the
paraventricular nucleus of PWS patients. Recent data were obtained studying OT in patients
with autism which showed a link between the deregulation of OT and the autistic pathology.
Clinical and imaging studies obtained with PWS and autistic populations make us believe that
some mechanisms are common between these two pathologies.
The objectives of this project are:
1. to look for an influence on the understanding of the social codes of the PWS patients,
2. to look for an influence on the behavior of stress and anxiety and on the regulation of
eating habits when patients receive a nasal pulverizing of OT.
Recent clinical studies showed that the oxytocin (OT), next to its long-time known actions
(lactation, satiety), participates in the regulation of the social behavior. Swaab and al in
1995 showed a significant reduction in number and in volume of neurons expressing OT in the
paraventricular nucleus of PWS patients. Recent data suggest a link between OT and the
autistic pathology: the existence of a lower plasmatic rate on OT and the association with a
polymorphism of the OT's receptor for autistics patients. Because OT has a role on the
pro-social behavior and on the nervous control of the stress, the hypothesis on which a
deficit in OT would play a role in the abnormalities of the social behavior was advanced.
Moreover, certain features of the autistic spectrum disorder can be found in PWS patients.
Moreover, a recent study has shown that OT administered by intra-nasal spray reduces
psychosocial stress and increases the confidence in each other in healthy volunteers. The
PWS is a genetic pathology and some clinical features are very similar to the autistic
pathology. The PWS is the most common cause of syndromic autism. Data from the literature
and a collaborative study conducted between our team and the Prof. B. Rogé's team suggests
that these two pathologies share common pathophysiological mechanisms. To our knowledge, no
study with the OT was conducted in people with PWS. We want to conduct a pilot study in
adult patients with PWS. Given the severity of this disease, related to socialization
disorders, significant anxiety and overeating, and with no effective therapy, this justifies
the pilot study. Moreover, side effects of OT are almost nonexistent when used by
intra-nasal.
Objectives: The objectives of this project are to investigate whether the administration by
intra-nasal spray of OT plays a role on the understanding of social codes of PWS adult
patients. We also analyze its effect on the level of stress, anxiety and eating behavior.
Methodology: This study is a double blind control study. We will include 24 PWS patients,
aged over 18 years recruited at the Hendaye Marine Hospital (associated with the PWS
reference center whose coordination is in Toulouse). The hospital routinely receives PWS
adults for a 4 weeks stay which gives optimal conditions for the establishment of this
study. Patients are separated into 2 groups matched one by one on the sex and IQ. One group
receives the OT, the other a placebo. Forty five minutes after inhalation, all of the
patients are evaluated on their social comprehension thanks to psychometric tests.
Furthermore, an analysis based on observation sheets allows us to score daily stress,
anxiety and eating behavior. These sheets serve for the comparison between 2 days before and
2 days after the nasal spray on the above described scoring components.
Results: Differences between the two groups will be statistically analyzed by non parametric
statistical tests such as Mann-Whitney's test.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00742664 -
Behavioral Treatment of Obsessive-Compulsive Symptoms in Youth With Prader-Willi Syndrome: A Pilot Project
|
Phase 1/Phase 2 | |
Completed |
NCT02011360 -
Prader-Willi Syndrome Macronutrient Study
|
N/A | |
Completed |
NCT02205034 -
Evaluation of Tolerance, Suckling and Food Intake After Repeated Nasals Administrations of Oxytocin in PWS Infants
|
Phase 1/Phase 2 | |
Recruiting |
NCT02058342 -
Family-based Intervention for Youth With Prader-Willi Syndrome: The Active Play at Home Study
|
N/A | |
Completed |
NCT02013258 -
Oxytocin Trial in Prader-Willi Syndrome
|
Phase 1 | |
Completed |
NCT02368379 -
Diagnosis of Central Adrenal Insufficiency in Patients With Prader-Willi Syndrome
|
N/A | |
Completed |
NCT01897363 -
Hypoglycemia in Prader-Willi Syndrome
|
N/A | |
Completed |
NCT01404624 -
Characterization of Transcriptional Regulators of Ghrelin Hormone Which Causes Genetic Obesity
|
N/A | |
Completed |
NCT02464514 -
Macronutrient Regulation of Ghrelin and Peptide YY
|
N/A | |
Terminated |
NCT01542242 -
Liraglutide Use in Prader-Willi Syndrome
|
Phase 4 | |
Completed |
NCT00474643 -
Correlation of Hyperghrelinemia With Carotid Artery Intima-Media Thickness in Children With Prader-Willi Syndrome
|
N/A | |
Not yet recruiting |
NCT02728544 -
Post Exercise Irisin Levels in PWS Patients
|
N/A |